Lexicon Pharmaceuticals, Inc.
LXRX
$1.62
$0.010.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -59.56% | -55.12% | -55.15% | -45.21% | 39.95% |
| Total Receivables | -31.36% | -19.38% | -16.68% | 3,009.24% | 243.86% |
| Inventory | 21.65% | -75.16% | -71.28% | -60.89% | -39.37% |
| Prepaid Expenses | -33.80% | -39.08% | -51.45% | -52.65% | -11.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -58.61% | -54.38% | -54.78% | -32.59% | 39.45% |
|
|
|||||
| Total Current Assets | -58.61% | -54.38% | -54.78% | -32.59% | 39.45% |
| Net Property, Plant & Equipment | 25.49% | 32.79% | -7.74% | -3.43% | -2.60% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7,880.43% | 3,446.86% | 3,446.86% | -55.56% | -55.56% |
| Total Assets | -38.01% | -35.87% | -39.58% | -28.65% | 30.07% |
|
|
|||||
| Total Accounts Payable | -79.17% | -73.26% | -51.73% | 32.50% | 2.86% |
| Total Accrued Expenses | -60.55% | -41.70% | -26.40% | -15.22% | 84.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 430.81% | 26.21% | -29.59% | 3,238.50% | -8.99% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -53.88% | -39.74% | 24.97% | 373.07% | 43.43% |
|
|
|||||
| Total Current Liabilities | -53.88% | -39.74% | 24.97% | 373.07% | 43.43% |
| Long-Term Debt | -50.74% | -43.43% | -43.61% | -41.28% | 0.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 45.39% | -9.95% | -11.01% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.61% | -62.87% | -28.25% | -- | -- |
| Total Liabilities | -49.20% | -39.86% | -27.92% | 36.06% | 11.85% |
|
|
|||||
| Common Stock & APIC | 0.59% | 0.53% | 0.50% | 0.57% | 13.68% |
| Retained Earnings | -2.56% | -3.55% | -6.45% | -9.77% | -11.34% |
| Treasury Stock & Other | -14.70% | -20.91% | -8.17% | -10.65% | -57.53% |
| Total Common Equity | -26.32% | -32.69% | -46.06% | -57.41% | 56.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.32% | -32.69% | -46.06% | -57.41% | 56.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.32% | -32.69% | -46.06% | -57.41% | 56.75% |
|
|
|||||